Novo Nordisk Aktie
44,69
EUR
-0,11
EUR
-0,25
%
44,56
EUR
-1,00
EUR
-2,19
%
Werbung
Novo Nordisk Aktie Analyse
| 02.02.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 02.02.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.18 | Novo Nordisk buy | UBS AG | |
| 26.01.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 26.01.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 22.01.18 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.01.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 19.01.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 17.01.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 16.01.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 16.01.18 | Novo Nordisk market-perform | Bernstein Research | |
| 15.01.18 | Novo Nordisk buy | UBS AG | |
| 12.01.18 | Novo Nordisk buy | UBS AG | |
| 09.01.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 09.01.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 08.01.18 | Novo Nordisk buy | UBS AG | |
| 29.12.17 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 15.12.17 | Novo Nordisk Verkaufen | DZ BANK | |
| 12.12.17 | Novo Nordisk buy | UBS AG | |
| 07.12.17 | Novo Nordisk Reduce | HSBC | |
| 06.12.17 | Novo Nordisk overweight | Morgan Stanley | |
| 06.12.17 | Novo Nordisk buy | UBS AG | |
| 06.12.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 06.12.17 | Novo Nordisk buy | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 06.12.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.12.17 | Novo Nordisk overweight | Morgan Stanley | |
| 28.11.17 | Novo Nordisk buy | UBS AG | |
| 22.11.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 22.11.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 22.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 16.11.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 15.11.17 | Novo Nordisk Underweight | Barclays Capital | |
| 03.11.17 | Novo Nordisk Hold | S&P Capital IQ | |
| 02.11.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 02.11.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 02.11.17 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 02.11.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 02.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.11.17 | Novo Nordisk buy | UBS AG | |
| 27.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 26.10.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 23.10.17 | Novo Nordisk buy | UBS AG | |
| 20.10.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 19.10.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 19.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 17.10.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 17.10.17 | Novo Nordisk buy | UBS AG | |
| 17.10.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 17.10.17 | Novo Nordisk Reduce | HSBC | |
Werbung
Werbung